115 related articles for article (PubMed ID: 15797521)
1. Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
Caputo E; Lombardi ML; Luongo V; Moharram R; Tornatore P; Pirozzi G; Guardiola J; Martin BM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):59-66. PubMed ID: 15797521
[TBL] [Abstract][Full Text] [Related]
2. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
3. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
Gonçalves A; Bertucci F; Birnbaum D; Borg JP
Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
[TBL] [Abstract][Full Text] [Related]
4. Proteomic characterization of inter-alpha inhibitor proteins from human plasma.
Josic D; Brown MK; Huang F; Lim YP; Rucevic M; Clifton JG; Hixson DC
Proteomics; 2006 May; 6(9):2874-85. PubMed ID: 16596706
[TBL] [Abstract][Full Text] [Related]
5. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
[TBL] [Abstract][Full Text] [Related]
6. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
7. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
8. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
9. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometric identification of serum peptides employing derivatized poly(glycidyl methacrylate/divinyl benzene) particles and mu-HPLC.
Rainer M; Najam-ul-Haq M; Bakry R; Huck CW; Bonn GK
J Proteome Res; 2007 Jan; 6(1):382-6. PubMed ID: 17203982
[TBL] [Abstract][Full Text] [Related]
11. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
12. [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].
Lakomý R'; Greplová K; Pilný R; Budinská E; Valík D; Poprach A; Nemecek R; Vyzula R
Klin Onkol; 2009; 22(5):228-32. PubMed ID: 19886361
[TBL] [Abstract][Full Text] [Related]
13. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
14. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
15. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
[TBL] [Abstract][Full Text] [Related]
17. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
18. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach.
Caputo E; Camarca A; Moharram R; Tornatore P; Thatcher B; Guardiola J; Martin BM
Biochemistry; 2003 May; 42(20):6169-78. PubMed ID: 12755619
[TBL] [Abstract][Full Text] [Related]
19. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ
Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629
[TBL] [Abstract][Full Text] [Related]
20. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
